nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0626	0.213	CbGbCtD
Zonisamide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0626	0.213	CbGbCtD
Zonisamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0399	0.136	CbGbCtD
Zonisamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.027	0.092	CbGbCtD
Zonisamide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0263	0.0897	CbGbCtD
Zonisamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0257	0.0878	CbGbCtD
Zonisamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0229	0.0782	CbGbCtD
Zonisamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0135	0.0459	CbGbCtD
Zonisamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0127	0.0433	CbGbCtD
Zonisamide—SCN4B—bronchus—chronic obstructive pulmonary disease	0.00636	0.0593	CbGeAlD
Zonisamide—SCN4B—trachea—chronic obstructive pulmonary disease	0.00571	0.0532	CbGeAlD
Zonisamide—CA11—bronchus—chronic obstructive pulmonary disease	0.00548	0.051	CbGeAlD
Zonisamide—SCN1B—lung—chronic obstructive pulmonary disease	0.00523	0.0487	CbGeAlD
Zonisamide—CA11—trachea—chronic obstructive pulmonary disease	0.00492	0.0458	CbGeAlD
Zonisamide—SCN3B—lung—chronic obstructive pulmonary disease	0.00483	0.045	CbGeAlD
Zonisamide—CA13—lung—chronic obstructive pulmonary disease	0.00421	0.0392	CbGeAlD
Zonisamide—SCN4B—lung—chronic obstructive pulmonary disease	0.00411	0.0382	CbGeAlD
Zonisamide—CA3—respiratory system—chronic obstructive pulmonary disease	0.00406	0.0378	CbGeAlD
Zonisamide—CA3—connective tissue—chronic obstructive pulmonary disease	0.00358	0.0333	CbGeAlD
Zonisamide—CA11—lung—chronic obstructive pulmonary disease	0.00353	0.0329	CbGeAlD
Zonisamide—CA7—trachea—chronic obstructive pulmonary disease	0.00327	0.0305	CbGeAlD
Zonisamide—CA12—respiratory system—chronic obstructive pulmonary disease	0.00288	0.0268	CbGeAlD
Zonisamide—CACNA1H—smooth muscle tissue—chronic obstructive pulmonary disease	0.00273	0.0254	CbGeAlD
Zonisamide—CA12—connective tissue—chronic obstructive pulmonary disease	0.00253	0.0236	CbGeAlD
Zonisamide—CA1—respiratory system—chronic obstructive pulmonary disease	0.00228	0.0212	CbGeAlD
Zonisamide—CA3—lung—chronic obstructive pulmonary disease	0.00216	0.0201	CbGeAlD
Zonisamide—CA12—trachea—chronic obstructive pulmonary disease	0.00213	0.0198	CbGeAlD
Zonisamide—AOX1—bronchus—chronic obstructive pulmonary disease	0.00197	0.0184	CbGeAlD
Zonisamide—SCN9A—lung—chronic obstructive pulmonary disease	0.00192	0.0179	CbGeAlD
Zonisamide—MAOB—respiratory system—chronic obstructive pulmonary disease	0.00185	0.0172	CbGeAlD
Zonisamide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00178	0.0166	CbGeAlD
Zonisamide—AOX1—trachea—chronic obstructive pulmonary disease	0.00177	0.0165	CbGeAlD
Zonisamide—SCN1A—lung—chronic obstructive pulmonary disease	0.00165	0.0154	CbGeAlD
Zonisamide—MAOB—connective tissue—chronic obstructive pulmonary disease	0.00163	0.0152	CbGeAlD
Zonisamide—MAOA—respiratory system—chronic obstructive pulmonary disease	0.00158	0.0147	CbGeAlD
Zonisamide—CA12—lung—chronic obstructive pulmonary disease	0.00153	0.0142	CbGeAlD
Zonisamide—MAOB—bronchus—chronic obstructive pulmonary disease	0.00152	0.0142	CbGeAlD
Zonisamide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00148	0.0138	CbGeAlD
Zonisamide—MAOA—connective tissue—chronic obstructive pulmonary disease	0.00139	0.0129	CbGeAlD
Zonisamide—CA5B—lung—chronic obstructive pulmonary disease	0.00137	0.0128	CbGeAlD
Zonisamide—SCN3A—lung—chronic obstructive pulmonary disease	0.00133	0.0124	CbGeAlD
Zonisamide—CA4—trachea—chronic obstructive pulmonary disease	0.00132	0.0123	CbGeAlD
Zonisamide—CA2—connective tissue—chronic obstructive pulmonary disease	0.0013	0.0121	CbGeAlD
Zonisamide—MAOA—bronchus—chronic obstructive pulmonary disease	0.0013	0.0121	CbGeAlD
Zonisamide—AOX1—lung—chronic obstructive pulmonary disease	0.00127	0.0119	CbGeAlD
Zonisamide—CA2—bronchus—chronic obstructive pulmonary disease	0.00122	0.0113	CbGeAlD
Zonisamide—CA1—lung—chronic obstructive pulmonary disease	0.00121	0.0113	CbGeAlD
Zonisamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00119	0.0111	CbGeAlD
Zonisamide—MAOA—trachea—chronic obstructive pulmonary disease	0.00117	0.0109	CbGeAlD
Zonisamide—CA2—trachea—chronic obstructive pulmonary disease	0.00109	0.0102	CbGeAlD
Zonisamide—MAOB—lung—chronic obstructive pulmonary disease	0.000982	0.00914	CbGeAlD
Zonisamide—CA4—lung—chronic obstructive pulmonary disease	0.000946	0.00881	CbGeAlD
Zonisamide—MAOA—lung—chronic obstructive pulmonary disease	0.000838	0.0078	CbGeAlD
Zonisamide—CA2—lung—chronic obstructive pulmonary disease	0.000784	0.0073	CbGeAlD
Zonisamide—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000459	0.00103	CcSEcCtD
Zonisamide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00103	CcSEcCtD
Zonisamide—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00103	CcSEcCtD
Zonisamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000455	0.00102	CcSEcCtD
Zonisamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000455	0.00102	CcSEcCtD
Zonisamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00102	CcSEcCtD
Zonisamide—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000454	0.00102	CcSEcCtD
Zonisamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00102	CcSEcCtD
Zonisamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00102	CcSEcCtD
Zonisamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00101	CcSEcCtD
Zonisamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00101	CcSEcCtD
Zonisamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00101	CcSEcCtD
Zonisamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000448	0.00101	CcSEcCtD
Zonisamide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.001	CcSEcCtD
Zonisamide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000446	0.001	CcSEcCtD
Zonisamide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000446	0.001	CcSEcCtD
Zonisamide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000445	0.001	CcSEcCtD
Zonisamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000445	0.001	CcSEcCtD
Zonisamide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.000999	CcSEcCtD
Zonisamide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000444	0.000999	CcSEcCtD
Zonisamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.000996	CcSEcCtD
Zonisamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000443	0.000996	CcSEcCtD
Zonisamide—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000442	0.000995	CcSEcCtD
Zonisamide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.000994	CcSEcCtD
Zonisamide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000442	0.000994	CcSEcCtD
Zonisamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00044	0.000991	CcSEcCtD
Zonisamide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.000986	CcSEcCtD
Zonisamide—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000437	0.000985	CcSEcCtD
Zonisamide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000437	0.000983	CcSEcCtD
Zonisamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000436	0.000981	CcSEcCtD
Zonisamide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000433	0.000974	CcSEcCtD
Zonisamide—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000431	0.00097	CcSEcCtD
Zonisamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.000966	CcSEcCtD
Zonisamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00096	CcSEcCtD
Zonisamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000425	0.000956	CcSEcCtD
Zonisamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.000956	CcSEcCtD
Zonisamide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000425	0.000956	CcSEcCtD
Zonisamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000423	0.000951	CcSEcCtD
Zonisamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000422	0.000951	CcSEcCtD
Zonisamide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.000948	CcSEcCtD
Zonisamide—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000947	CcSEcCtD
Zonisamide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.000943	CcSEcCtD
Zonisamide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.000939	CcSEcCtD
Zonisamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000415	0.000934	CcSEcCtD
Zonisamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.000934	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.000932	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000414	0.000932	CcSEcCtD
Zonisamide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.000926	CcSEcCtD
Zonisamide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000411	0.000926	CcSEcCtD
Zonisamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.000921	CcSEcCtD
Zonisamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000409	0.00092	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000406	0.000913	CcSEcCtD
Zonisamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.000912	CcSEcCtD
Zonisamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000405	0.000912	CcSEcCtD
Zonisamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000404	0.00091	CcSEcCtD
Zonisamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.00091	CcSEcCtD
Zonisamide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000403	0.000907	CcSEcCtD
Zonisamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.000903	CcSEcCtD
Zonisamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0004	0.000901	CcSEcCtD
Zonisamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.000901	CcSEcCtD
Zonisamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0004	0.0009	CcSEcCtD
Zonisamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.000897	CcSEcCtD
Zonisamide—Injury—Prednisone—chronic obstructive pulmonary disease	0.000396	0.000892	CcSEcCtD
Zonisamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000396	0.000891	CcSEcCtD
Zonisamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000395	0.000889	CcSEcCtD
Zonisamide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.000887	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.000884	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000393	0.000884	CcSEcCtD
Zonisamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000392	0.000882	CcSEcCtD
Zonisamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.000882	CcSEcCtD
Zonisamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000392	0.000882	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00088	CcSEcCtD
Zonisamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000389	0.000875	CcSEcCtD
Zonisamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.000875	CcSEcCtD
Zonisamide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.000874	CcSEcCtD
Zonisamide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000388	0.000872	CcSEcCtD
Zonisamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.000868	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000385	0.000865	CcSEcCtD
Zonisamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000384	0.000864	CcSEcCtD
Zonisamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.000862	CcSEcCtD
Zonisamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.000859	CcSEcCtD
Zonisamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.000855	CcSEcCtD
Zonisamide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.000852	CcSEcCtD
Zonisamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.000851	CcSEcCtD
Zonisamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.000848	CcSEcCtD
Zonisamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000376	0.000847	CcSEcCtD
Zonisamide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.000845	CcSEcCtD
Zonisamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000375	0.000843	CcSEcCtD
Zonisamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.000843	CcSEcCtD
Zonisamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.000842	CcSEcCtD
Zonisamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00084	CcSEcCtD
Zonisamide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000373	0.00084	CcSEcCtD
Zonisamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000373	0.000839	CcSEcCtD
Zonisamide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000372	0.000837	CcSEcCtD
Zonisamide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.000837	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.000834	CcSEcCtD
Zonisamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.000833	CcSEcCtD
Zonisamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.000826	CcSEcCtD
Zonisamide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00082	CcSEcCtD
Zonisamide—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000819	CcSEcCtD
Zonisamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.000813	CcSEcCtD
Zonisamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000361	0.000813	CcSEcCtD
Zonisamide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.000809	CcSEcCtD
Zonisamide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00036	0.000809	CcSEcCtD
Zonisamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00036	0.000809	CcSEcCtD
Zonisamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.000809	CcSEcCtD
Zonisamide—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000358	0.000807	CcSEcCtD
Zonisamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.000806	CcSEcCtD
Zonisamide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000356	0.0008	CcSEcCtD
Zonisamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.0008	CcSEcCtD
Zonisamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.000799	CcSEcCtD
Zonisamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000355	0.000799	CcSEcCtD
Zonisamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000354	0.000796	CcSEcCtD
Zonisamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.000796	CcSEcCtD
Zonisamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.000794	CcSEcCtD
Zonisamide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000353	0.000794	CcSEcCtD
Zonisamide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000352	0.000792	CcSEcCtD
Zonisamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000352	0.000792	CcSEcCtD
Zonisamide—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000352	0.000791	CcSEcCtD
Zonisamide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00079	CcSEcCtD
Zonisamide—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000782	CcSEcCtD
Zonisamide—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000776	CcSEcCtD
Zonisamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.000768	CcSEcCtD
Zonisamide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.000764	CcSEcCtD
Zonisamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.000764	CcSEcCtD
Zonisamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000335	0.000754	CcSEcCtD
Zonisamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.000754	CcSEcCtD
Zonisamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.000753	CcSEcCtD
Zonisamide—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000751	CcSEcCtD
Zonisamide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000331	0.000746	CcSEcCtD
Zonisamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000739	CcSEcCtD
Zonisamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.000734	CcSEcCtD
Zonisamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000326	0.000734	CcSEcCtD
Zonisamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.000724	CcSEcCtD
Zonisamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000322	0.000724	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000723	CcSEcCtD
Zonisamide—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000723	CcSEcCtD
Zonisamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00032	0.000719	CcSEcCtD
Zonisamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000712	CcSEcCtD
Zonisamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000315	0.000709	CcSEcCtD
Zonisamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000311	0.0007	CcSEcCtD
Zonisamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.0007	CcSEcCtD
Zonisamide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000694	CcSEcCtD
Zonisamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.000693	CcSEcCtD
Zonisamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000305	0.000686	CcSEcCtD
Zonisamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.000684	CcSEcCtD
Zonisamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000301	0.000677	CcSEcCtD
Zonisamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.000677	CcSEcCtD
Zonisamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000295	0.000663	CcSEcCtD
Zonisamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.000661	CcSEcCtD
Zonisamide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000652	CcSEcCtD
Zonisamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.000651	CcSEcCtD
Zonisamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000289	0.000651	CcSEcCtD
Zonisamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.000645	CcSEcCtD
Zonisamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000287	0.000645	CcSEcCtD
Zonisamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000286	0.000645	CcSEcCtD
Zonisamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.000645	CcSEcCtD
Zonisamide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000645	CcSEcCtD
Zonisamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000285	0.000641	CcSEcCtD
Zonisamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.000641	CcSEcCtD
Zonisamide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000641	CcSEcCtD
Zonisamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.000639	CcSEcCtD
Zonisamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000283	0.000637	CcSEcCtD
Zonisamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000281	0.000632	CcSEcCtD
Zonisamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000281	0.000631	CcSEcCtD
Zonisamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00063	CcSEcCtD
Zonisamide—Depression—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00063	CcSEcCtD
Zonisamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000279	0.000628	CcSEcCtD
Zonisamide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000619	CcSEcCtD
Zonisamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.000614	CcSEcCtD
Zonisamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.000612	CcSEcCtD
Zonisamide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00061	CcSEcCtD
Zonisamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.000609	CcSEcCtD
Zonisamide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.000609	CcSEcCtD
Zonisamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.000609	CcSEcCtD
Zonisamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.000608	CcSEcCtD
Zonisamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00027	0.000608	CcSEcCtD
Zonisamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.000605	CcSEcCtD
Zonisamide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.000597	CcSEcCtD
Zonisamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000265	0.000595	CcSEcCtD
Zonisamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.000588	CcSEcCtD
Zonisamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.000586	CcSEcCtD
Zonisamide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000577	CcSEcCtD
Zonisamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.000574	CcSEcCtD
Zonisamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.000571	CcSEcCtD
Zonisamide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000564	CcSEcCtD
Zonisamide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000557	CcSEcCtD
Zonisamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.000554	CcSEcCtD
Zonisamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000545	CcSEcCtD
Zonisamide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.000541	CcSEcCtD
Zonisamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000536	CcSEcCtD
Zonisamide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00053	CcSEcCtD
Zonisamide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000512	CcSEcCtD
Zonisamide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000501	CcSEcCtD
Zonisamide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000501	CcSEcCtD
Zonisamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000498	CcSEcCtD
Zonisamide—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000497	CcSEcCtD
Zonisamide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000493	CcSEcCtD
Zonisamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000458	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000457	CcSEcCtD
Zonisamide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000456	CcSEcCtD
Zonisamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000453	CcSEcCtD
Zonisamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000445	CcSEcCtD
Zonisamide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000443	CcSEcCtD
Zonisamide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000443	CcSEcCtD
Zonisamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00044	CcSEcCtD
Zonisamide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000434	CcSEcCtD
Zonisamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000428	CcSEcCtD
Zonisamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000426	CcSEcCtD
Zonisamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00042	CcSEcCtD
Zonisamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00042	CcSEcCtD
Zonisamide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000419	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000417	CcSEcCtD
Zonisamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000415	CcSEcCtD
Zonisamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000408	CcSEcCtD
Zonisamide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000403	CcSEcCtD
Zonisamide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000178	0.0004	CcSEcCtD
Zonisamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000396	CcSEcCtD
Zonisamide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000395	CcSEcCtD
Zonisamide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000393	CcSEcCtD
Zonisamide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000391	CcSEcCtD
Zonisamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000389	CcSEcCtD
Zonisamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000384	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000367	CcSEcCtD
Zonisamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000367	CcSEcCtD
Zonisamide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000364	CcSEcCtD
Zonisamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000362	CcSEcCtD
Zonisamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000355	CcSEcCtD
Zonisamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00035	CcSEcCtD
Zonisamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000349	CcSEcCtD
Zonisamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000349	CcSEcCtD
Zonisamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000347	CcSEcCtD
Zonisamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000347	CcSEcCtD
Zonisamide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000344	CcSEcCtD
Zonisamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000332	CcSEcCtD
Zonisamide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000329	CcSEcCtD
Zonisamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000329	CcSEcCtD
Zonisamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00032	CcSEcCtD
Zonisamide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000318	CcSEcCtD
Zonisamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000318	CcSEcCtD
Zonisamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000297	CcSEcCtD
Zonisamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000289	CcSEcCtD
Zonisamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000285	CcSEcCtD
Zonisamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000276	CcSEcCtD
Zonisamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000266	CcSEcCtD
Zonisamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000256	CcSEcCtD
Zonisamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000254	CcSEcCtD
Zonisamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000254	CcSEcCtD
Zonisamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000252	CcSEcCtD
Zonisamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000239	CcSEcCtD
Zonisamide—SCN11A—Axon guidance—IL6—chronic obstructive pulmonary disease	8.97e-05	0.000579	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	8.96e-05	0.000578	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.9e-05	0.000574	CbGpPWpGaD
Zonisamide—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.9e-05	0.000574	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.87e-05	0.000572	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	8.82e-05	0.000569	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	8.82e-05	0.000569	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—EGFR—chronic obstructive pulmonary disease	8.79e-05	0.000567	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—EGFR—chronic obstructive pulmonary disease	8.79e-05	0.000567	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—EGFR—chronic obstructive pulmonary disease	8.64e-05	0.000557	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.61e-05	0.000555	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	8.52e-05	0.000549	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.51e-05	0.000549	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.51e-05	0.000549	CbGpPWpGaD
Zonisamide—CA3—Metabolism—ALB—chronic obstructive pulmonary disease	8.51e-05	0.000549	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	8.5e-05	0.000548	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	8.5e-05	0.000548	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.42e-05	0.000543	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.42e-05	0.000543	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TNF—chronic obstructive pulmonary disease	8.37e-05	0.00054	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.35e-05	0.000538	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	8.33e-05	0.000537	CbGpPWpGaD
Zonisamide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.31e-05	0.000536	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.31e-05	0.000536	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.29e-05	0.000535	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.29e-05	0.000535	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—EGFR—chronic obstructive pulmonary disease	8.26e-05	0.000533	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.25e-05	0.000532	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.23e-05	0.000531	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.16e-05	0.000526	CbGpPWpGaD
Zonisamide—CA3—Metabolism—NOS3—chronic obstructive pulmonary disease	8.14e-05	0.000525	CbGpPWpGaD
Zonisamide—AOX1—Disease—HDAC2—chronic obstructive pulmonary disease	8.12e-05	0.000524	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.12e-05	0.000524	CbGpPWpGaD
Zonisamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.12e-05	0.000524	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.1e-05	0.000522	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.09e-05	0.000522	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.07e-05	0.000521	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.07e-05	0.00052	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MMP9—chronic obstructive pulmonary disease	8.02e-05	0.000517	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GCLC—chronic obstructive pulmonary disease	8e-05	0.000516	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.94e-05	0.000512	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.94e-05	0.000512	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TNF—chronic obstructive pulmonary disease	7.93e-05	0.000512	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.9e-05	0.00051	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.86e-05	0.000507	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.86e-05	0.000507	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	7.85e-05	0.000507	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.8e-05	0.000503	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.76e-05	0.000501	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.76e-05	0.000501	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.74e-05	0.000499	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.74e-05	0.000499	CbGpPWpGaD
Zonisamide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.7e-05	0.000496	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.67e-05	0.000495	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.65e-05	0.000493	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.63e-05	0.000492	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.56e-05	0.000488	CbGpPWpGaD
Zonisamide—AOX1—Disease—KL—chronic obstructive pulmonary disease	7.55e-05	0.000487	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.46e-05	0.000481	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.46e-05	0.000481	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.44e-05	0.00048	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.42e-05	0.000478	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.34e-05	0.000473	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.34e-05	0.000473	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.3e-05	0.000471	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.3e-05	0.000471	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.29e-05	0.00047	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.25e-05	0.000468	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	7.2e-05	0.000464	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.17e-05	0.000462	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.17e-05	0.000462	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.17e-05	0.000462	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.15e-05	0.000461	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.14e-05	0.000461	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.000456	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.06e-05	0.000455	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.01e-05	0.000452	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.01e-05	0.000452	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—IL6—chronic obstructive pulmonary disease	6.98e-05	0.00045	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.97e-05	0.00045	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.86e-05	0.000442	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.85e-05	0.000442	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.84e-05	0.000441	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.8e-05	0.000438	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GCLC—chronic obstructive pulmonary disease	6.76e-05	0.000436	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—IL6—chronic obstructive pulmonary disease	6.76e-05	0.000436	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.76e-05	0.000436	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—IL6—chronic obstructive pulmonary disease	6.75e-05	0.000436	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.73e-05	0.000434	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.66e-05	0.000429	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—IL6—chronic obstructive pulmonary disease	6.64e-05	0.000428	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.61e-05	0.000426	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.58e-05	0.000424	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.55e-05	0.000422	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.54e-05	0.000422	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.48e-05	0.000418	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	6.44e-05	0.000415	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—IL6—chronic obstructive pulmonary disease	6.4e-05	0.000413	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.4e-05	0.000413	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—IL6—chronic obstructive pulmonary disease	6.35e-05	0.000409	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.29e-05	0.000406	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.29e-05	0.000406	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.28e-05	0.000405	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.27e-05	0.000405	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.22e-05	0.000401	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TNF—chronic obstructive pulmonary disease	6.17e-05	0.000398	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	6.17e-05	0.000398	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	6.16e-05	0.000397	CbGpPWpGaD
Zonisamide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.14e-05	0.000396	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—IL6—chronic obstructive pulmonary disease	6.1e-05	0.000393	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—IL6—chronic obstructive pulmonary disease	6.1e-05	0.000393	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.07e-05	0.000391	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.03e-05	0.000389	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	6.01e-05	0.000388	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.98e-05	0.000386	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.98e-05	0.000385	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.97e-05	0.000385	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.93e-05	0.000383	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.89e-05	0.00038	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	5.89e-05	0.00038	CbGpPWpGaD
Zonisamide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.88e-05	0.000379	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—IL6—chronic obstructive pulmonary disease	5.88e-05	0.000379	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.87e-05	0.000378	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.85e-05	0.000377	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.78e-05	0.000372	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.78e-05	0.000372	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.77e-05	0.000372	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.72e-05	0.000369	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.72e-05	0.000369	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.68e-05	0.000366	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.66e-05	0.000365	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.66e-05	0.000365	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB3—chronic obstructive pulmonary disease	5.66e-05	0.000365	CbGpPWpGaD
Zonisamide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.64e-05	0.000364	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.61e-05	0.000362	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.61e-05	0.000362	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.57e-05	0.000359	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.53e-05	0.000357	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.48e-05	0.000354	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	5.48e-05	0.000354	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.46e-05	0.000352	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.42e-05	0.00035	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.39e-05	0.000348	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.39e-05	0.000348	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.38e-05	0.000347	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	5.34e-05	0.000345	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	5.34e-05	0.000345	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.31e-05	0.000342	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.26e-05	0.000339	CbGpPWpGaD
Zonisamide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	5.24e-05	0.000338	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.2e-05	0.000335	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.2e-05	0.000335	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.15e-05	0.000332	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.11e-05	0.00033	CbGpPWpGaD
Zonisamide—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.11e-05	0.00033	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.03e-05	0.000324	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	4.99e-05	0.000322	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	4.99e-05	0.000322	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.98e-05	0.000321	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.98e-05	0.000321	CbGpPWpGaD
Zonisamide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.96e-05	0.00032	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.95e-05	0.000319	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.89e-05	0.000315	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.88e-05	0.000315	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.82e-05	0.000311	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	4.77e-05	0.000308	CbGpPWpGaD
Zonisamide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.77e-05	0.000308	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.75e-05	0.000306	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.74e-05	0.000306	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.74e-05	0.000305	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOS2—chronic obstructive pulmonary disease	4.72e-05	0.000304	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.67e-05	0.000301	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.62e-05	0.000298	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	4.62e-05	0.000298	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.55e-05	0.000293	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.53e-05	0.000292	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.49e-05	0.000289	CbGpPWpGaD
Zonisamide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	4.42e-05	0.000285	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.38e-05	0.000283	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.36e-05	0.000281	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.35e-05	0.000281	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.35e-05	0.000281	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.000278	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.29e-05	0.000277	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.27e-05	0.000275	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.25e-05	0.000274	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	4.24e-05	0.000274	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.2e-05	0.000271	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.13e-05	0.000267	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.13e-05	0.000266	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.11e-05	0.000265	CbGpPWpGaD
Zonisamide—AOX1—Disease—SERPINE1—chronic obstructive pulmonary disease	3.97e-05	0.000256	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.92e-05	0.000253	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	3.87e-05	0.00025	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.84e-05	0.000248	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.82e-05	0.000246	CbGpPWpGaD
Zonisamide—AOX1—Disease—NOS3—chronic obstructive pulmonary disease	3.79e-05	0.000245	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.79e-05	0.000244	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.72e-05	0.00024	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	3.68e-05	0.000238	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.66e-05	0.000236	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.57e-05	0.00023	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	3.53e-05	0.000228	CbGpPWpGaD
Zonisamide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.52e-05	0.000227	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.47e-05	0.000224	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.46e-05	0.000223	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	3.39e-05	0.000218	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.38e-05	0.000218	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ALB—chronic obstructive pulmonary disease	3.32e-05	0.000214	CbGpPWpGaD
Zonisamide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-05	0.000209	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.18e-05	0.000205	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	2.98e-05	0.000192	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.97e-05	0.000192	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.95e-05	0.00019	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.93e-05	0.000189	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.85e-05	0.000184	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	2.81e-05	0.000181	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.75e-05	0.000178	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.000176	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	2.68e-05	0.000173	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.000167	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFB1—chronic obstructive pulmonary disease	2.51e-05	0.000162	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—chronic obstructive pulmonary disease	2.46e-05	0.000159	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.3e-05	0.000148	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.24e-05	0.000144	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.08e-05	0.000134	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.03e-05	0.000131	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000129	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—chronic obstructive pulmonary disease	1.89e-05	0.000122	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.87e-05	0.000121	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000118	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	1.76e-05	0.000114	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000109	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	1.68e-05	0.000109	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	9.08e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	8.95e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	8.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	7.91e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.22e-05	7.88e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.21e-05	7.79e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.1e-05	7.1e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	6.55e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.47e-06	5.46e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.35e-06	5.38e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	8.34e-06	5.38e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	7.97e-06	5.14e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.78e-06	5.02e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.37e-06	4.76e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.01e-06	3.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.79e-06	3.09e-05	CbGpPWpGaD
